Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2022

Relexxii(Methylphenidate Hcl)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$39K

Medicare cost, 2024

Medicare drug plans spent $39,088 on Relexxii (methylphenidate hcl) in 2024, for 77 prescriptions and refills filled by 26 patients. It was first approved in 2022.

Medicare cost, 2024

$39K

Prescriptions

77

$507.64 per claim

Patients

26

28 prescribers

Total spending, 2024

$39K

$1,503.38 per patient

Questions and answers

How much does Medicare spend on Relexxii?

Medicare prescription drug plans paid $39K for Relexxii in 2024, for 77 prescriptions and refills to 26 patients. The average cost per claim was $507.64.

Which state spends the most on Relexxii?

Minnesota had the highest Medicare cost for Relexxii in 2024: $5,726 for 16 claims.

Who prescribes Relexxii the most?

Jackie D Stevens, nurse practitioner in Zumbro Falls, MN, had the highest Medicare cost for Relexxii in 2024: 16 claims costing $5,726.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Relexxii, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Jackie D Stevens Zumbro Falls, MNNurse Practitioner16Under 11$5,726

Prescriber data by year

YearPrescribersClaimsPatientsCost
2024287726$39K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Vertical Pharm77$39K

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
11
RxNorm concept IDs
1091155, 1091170, 1091185, 1091210, 1995461
Application numbers
NDA216117

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube